Literature DB >> 8253805

Primary structure of the soluble lactose binding lectin L-29 from rat and dog and interaction of its non-collagenous proline-, glycine-, tyrosine-rich sequence with bacterial and tissue collagenase.

J Herrmann1, C W Turck, R E Atchison, M E Huflejt, L Poulter, M A Gitt, A L Burlingame, S H Barondes, H Leffler.   

Abstract

A lactose-binding lectin from rat lung (RL-29) and a related lectin from Madin-Darby canine kidney (MDCK) cells have been analyzed with the primary goal of identifying post-translational modifications. The sequences show that RL-29 and the dog lectin are homologues of a lectin designated here as L-29 and elsewhere as CBP-35, epsilon BP, Mac-2, or L-34. RL-29 has a 140-amino-acid COOH-terminal carbohydrate-binding domain, a 20-amino-acid NH2-terminal domain, and an intervening domain consisting of 11 repeating elements rich in Pro, Gly, and Tyr (R-domain). The dog homologue has 14 repeating elements in its R-domain explaining its larger size. The sensitivity of the R-domain to bacterial collagenase allowed us to isolate the NH2-terminal domain and show that the NH2 terminus was blocked by acetylation and, in the accompanying paper (Huflejt, M. E., Turck, C. W., Lindstedt, R., Barondes, S. H., and Leffler, H. (1993) J. Biol. Chem. 268, 26712-26718), that the NH2-terminal domain is phosphorylated. In addition, we unexpectedly found an endogenous component, resembling 92-kDa type IV collagenase, that co-purified with L-29 and slowly digested the R-domain. Hence, L-29 is a substrate for bacterial and tissue collagenases even though the R-domain is non-collagenous. Moreover, the co-purification suggests a non-enzymatic interaction between 92-kDa collagenase and L-29.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Kinetic measurements of binding of galectin 3 to a laminin substratum.

Authors:  E A Barboni; S Bawumia; R C Hughes
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

Review 2.  Seeing strangers or announcing "danger": galectin-3 in two models of innate immunity.

Authors:  Sachiko Sato; Julie Nieminen
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

3.  Expression of galectin-3 modulates T-cell growth and apoptosis.

Authors:  R Y Yang; D K Hsu; F T Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 4.  Key regulators of galectin-glycan interactions.

Authors:  Nourine A Kamili; Connie M Arthur; Christian Gerner-Smidt; Eden Tafesse; Anna Blenda; Marcelo Dias-Baruffi; Sean R Stowell
Journal:  Proteomics       Date:  2016-12       Impact factor: 3.984

5.  Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

Authors:  Malathy P V Shekhar; Pratima Nangia-Makker; Larry Tait; Fred Miller; Avraham Raz
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

6.  Galectin-3 Is a Target for Proteases Involved in the Virulence of Staphylococcus aureus.

Authors:  Jonas Elmwall; Jakub Kwiecinski; Manli Na; Abukar Ahmed Ali; Veronica Osla; Lindsey N Shaw; Wanzhong Wang; Karin Sävman; Elisabet Josefsson; Johan Bylund; Tao Jin; Amanda Welin; Anna Karlsson
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

Review 7.  Dynamics of galectin-3 in the nucleus and cytoplasm.

Authors:  Kevin C Haudek; Kimberly J Spronk; Patricia G Voss; Ronald J Patterson; John L Wang; Eric J Arnoys
Journal:  Biochim Biophys Acta       Date:  2009-07-16

Review 8.  Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus.

Authors:  Ronald J Patterson; Weizhong Wang; John L Wang
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

Review 9.  Galectin-3 and metastasis.

Authors:  Yukinori Takenaka; Tomoharu Fukumori; Avraham Raz
Journal:  Glycoconj J       Date:  2002       Impact factor: 2.916

10.  Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms.

Authors:  Michael C Carlsson; Per Bengtson; Helena Cucak; Hakon Leffler
Journal:  J Biol Chem       Date:  2013-08-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.